(Q35085026)

English

An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease

scientific article

Statements

An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease (English)
Giselle Domínguez Gutiérrez

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit